Abstract: The European Commission has approved Pfizer`s first-of-its-kind oral Janus kinase (JAK) inhibitor XELJANZ® (Tofacitinib)…
Tag:
Information
-
-
ChemIntelligence
FDA Grants AppliedVR Approval for First Virtual Reality Therapeutic to Treat Chronic Low Back Pain.
by adminSUMMARY: The U.S. Food and Drug Administration today authorized marketing of EaseVRx, a prescription-use immersive…
-
ChemIntelligence
Grão Direto Collaborates With Bayer to Expand the Reach And Impact of Sustainable Practices in Grain Trading.
by adminABSTRACT: The introduction of “Sustainable Practices Badge” seeks to encourage the adoption of more sustainable…